This module aims to develop and consolidate understanding of the skills, knowledge and attributes required for safe, and effective treatment of dermatological conditions. Successful completion will provide a deeper knowledge and understanding of the pharmacokinetics of topical and systemic treatments used to treat skin disease. Students will gain an increased understanding of key factors to consider when choosing treatment options including risk, cost, evidence about efficacy, disease severity, and patient's response to treatment, including potential adverse effects.

Dates:
8th, 9th, 10th, October 2025 (09.00-17.00) 27th, 28th Nov 2025 (09.00-17.00) Assessment - Jan 9th 2026 (am)

Venue:
All teaching is face to face at the University of Hertfordshire, College Lane Campus, Hatfield, Herts, AL10 9AB.

Content:

• Assessment and management of common skin conditions which will include acne eczema, psoriasis, skin infections (bacterial, viral, fungal), wounds, urticaria and infestations.
• A range of systemic and topical drug interventions for skin conditions including emollients, topical steroids, anti-infective / antimicrobial agents, wound dressings.
• Specialist drug treatments used in skin conditions, and drugs with special monitoring requirements such as methotrexate and other immunosuppressants, biologics, isotretinoin.
• Monitoring therapy to minimise adverse effects: adverse reactions to drug treatments for skin disease including drug eruptions and drug induced skin disease.
•  Professional and organisation policies / procedures / guidelines and codes of conduct relevant to interventions used to treat skin conditions.

Study Route:                                                                                                 

This module is compulsory for the MSc Clinical Dermatology. It is suitable for practitioners with an interest in dermatological conditions & will be of interest to FY1-2, GPs, Dermatology Nurses, Advanced Care Practitioners, hospital and retail Pharmacists who are managing people with skin conditions on a regular basis.

 Assessment:                                                                                                              

 Evidence-based treatment presentation – 30%

 Short Answer Test Patient Management - 70%

 Further information:   

Kathy Radley (Module Leader) k.radley@herts.ac.uk

Rebecca Penzer-Hick (Programme Leader) r.penzer-hick@herts.ac.uk

Madeleine Flanagan (Admissions)  m.flanagan@herts.ac.uk